These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

348 related items for PubMed ID: 11184768

  • 21. Serum erythropoietin in the diagnosis of polycythemia vera. A follow-up study.
    Remacha AF, Montserrat I, Santamaria A, Oliver A, Barceló MJ, Parellada M.
    Haematologica; 1997; 82(4):406-10. PubMed ID: 9299851
    [Abstract] [Full Text] [Related]

  • 22. A randomized controlled trial of a protease inhibitor (saquinavir) in combination with zidovudine in previously untreated patients with advanced HIV infection.
    Vella S, Lazzarin A, Carosi G, Sinicco A, Armignacco O, Angarano G, Andreoni M, Tambussi G, Chiodera A, Floridia M, Scaccabarozzi S, Facey K, Duncan I, Boudes P, Bragman K.
    Antivir Ther; 1996 Aug; 1(3):129-40. PubMed ID: 11322246
    [Abstract] [Full Text] [Related]

  • 23. Acute myelogenous leukaemia and myelomonocytic blast crisis following polycythemia vera in HIV positive patients: report of cases and review of the literature.
    Hentrich M, Rockstroh J, Sandner R, Brack N, Hartenstein R.
    Ann Oncol; 2000 Feb; 11(2):195-200. PubMed ID: 10761755
    [Abstract] [Full Text] [Related]

  • 24. [Polycythemia vera].
    Rain JD.
    Rev Prat; 2002 Oct 15; 52(16):1801-7. PubMed ID: 12564173
    [No Abstract] [Full Text] [Related]

  • 25. Immunological and virological activity of zalcitabine and zidovudine in combination in HIV-positive people with CD4 cell counts of between 200-500 cells/mm3.
    Ibáñez A, Peraire J, Arnó A, Gutiérrez C, Cervantes M, Colomer J, Villalonga C, Camafort M, Ruiz L, Balaguer M, Vidal F, Richart C, Clotet B.
    Antivir Ther; 1997 Apr 15; 2(2):105-11. PubMed ID: 11322274
    [Abstract] [Full Text] [Related]

  • 26. Results of the ALBI trial: a randomized comparison of stavudine/didanosine, zidovudine/lamivudine and alternating treatment in antiretroviral-naive patients.
    Molina JM, Chêuc G, Ferchal F, Journot V, Pellegrin I, Sombardier MN, Rancinan C, Cotte L, Madelaine I, Debord T, Decazes JM, ALBI (ANRS 070) Study Group.
    Antivir Ther; 1999 Apr 15; 4 Suppl 3():71-4. PubMed ID: 16021874
    [Abstract] [Full Text] [Related]

  • 27. Symptomatic Profiles of Patients With Polycythemia Vera: Implications of Inadequately Controlled Disease.
    Geyer H, Scherber R, Kosiorek H, Dueck AC, Kiladjian JJ, Xiao Z, Slot S, Zweegman S, Sackmann F, Fuentes AK, Hernández-Maraver D, Döhner K, Harrison CN, Radia D, Muxi P, Besses C, Cervantes F, Johansson PL, Andreasson B, Rambaldi A, Barbui T, Bonatz K, Reiter A, Boyer F, Etienne G, Ianotto JC, Ranta D, Roy L, Cahn JY, Maldonado N, Barosi G, Ferrari ML, Gale RP, Birgegard G, Xu Z, Zhang Y, Sun X, Xu J, Zhang P, te Boekhorst PA, Commandeur S, Schouten H, Pahl HL, Griesshammer M, Stegelmann F, Lehmann T, Senyak Z, Vannucchi AM, Passamonti F, Samuelsson J, Mesa RA.
    J Clin Oncol; 2016 Jan 10; 34(2):151-9. PubMed ID: 26598745
    [Abstract] [Full Text] [Related]

  • 28. Clinical and laboratory features, pathobiology of platelet-mediated thrombosis and bleeding complications, and the molecular etiology of essential thrombocythemia and polycythemia vera: therapeutic implications.
    Michiels JJ, Berneman Z, Van Bockstaele D, van der Planken M, De Raeve H, Schroyens W.
    Semin Thromb Hemost; 2006 Apr 10; 32(3):174-207. PubMed ID: 16673274
    [Abstract] [Full Text] [Related]

  • 29. Anticoagulant-resistant thrombophilia in a patient with polycythemia vera: a case report.
    Das S, Karachiwala H, Cherian SV, Garcha AS, Jasti S, Gajra A.
    Blood Coagul Fibrinolysis; 2011 Dec 10; 22(8):746-8. PubMed ID: 21885951
    [Abstract] [Full Text] [Related]

  • 30. [Severe thrombocytopenia and human immunodeficiency virus infection. Report of two cases and review].
    Pizarro P R, Aguad R L, Castro G JL.
    Rev Chilena Infectol; 2007 Feb 10; 24(1):63-7. PubMed ID: 17369974
    [Abstract] [Full Text] [Related]

  • 31. Strategies to decrease viral load rebound, and prevent loss of CD4 and onset of resistance during structured treatment interruptions.
    Foli A, Maserati R, Barasolo G, Castelli F, Tomasoni L, Migliorino M, Maggiolo F, Pan A, Paolucci S, Scudeller L, Tinelli C, D'Aquila R, Lisziewicz J, Lori F.
    Antivir Ther; 2004 Feb 10; 9(1):123-32. PubMed ID: 15040544
    [Abstract] [Full Text] [Related]

  • 32. Hydroxycarbamide associated platelet count oscillations in a patient with polycythaemia vera. A case report and review of the literature.
    Burthem J, Chaudhry MS.
    Platelets; 2008 May 10; 19(3):234-5. PubMed ID: 18432524
    [Abstract] [Full Text] [Related]

  • 33. Reductions in viral load and increases in T lymphocyte numbers in treatment-naive patients with advanced HIV-1 infection treated with ritonavir, zidovudine and zalcitabine triple therapy.
    Mathez D, Bagnarelli P, Gorin I, Katlama C, Pialoux G, Saimot G, Tubiana P, De Truchis P, Chauvin JP, Mills R, Rode R, Clementi M, Leibowitch J.
    Antivir Ther; 1997 Jul 10; 2(3):175-83. PubMed ID: 11322272
    [Abstract] [Full Text] [Related]

  • 34. Antiretroviral treatment. HIV infection in adults: better-defined first-line treatment.
    Prescrire Int; 2004 Aug 10; 13(72):144-50. PubMed ID: 15532140
    [Abstract] [Full Text] [Related]

  • 35. [Polycythaemia vera--diagnosis and therapy].
    Lechner K, Geissler K, Gisslinger H.
    Wien Klin Wochenschr; 1999 Aug 20; 111(15):582-9. PubMed ID: 10483672
    [Abstract] [Full Text] [Related]

  • 36. Polycythemia rubra vera.
    Bilgrami S, Greenberg BR.
    Semin Oncol; 1995 Aug 20; 22(4):307-26. PubMed ID: 7638629
    [Abstract] [Full Text] [Related]

  • 37. Biological and radiological investigations in patients with an increased red blood cell mass: Which are needed? Which are useful? which are unnecessary?
    Delannoy A.
    Nouv Rev Fr Hematol (1978); 1994 Apr 20; 36(2):159-63. PubMed ID: 8036133
    [Abstract] [Full Text] [Related]

  • 38. Leukemic transformation of polycythemia vera after treatment with hydroxyurea with abnormalities of chromosome 17.
    Tóthová E, Fricová M, Stecová N, Hlebasková M, Kafková A, Raffac S, Guman T, Svorcová E, Nebesnáková E.
    Neoplasma; 2001 Apr 20; 48(5):389-92. PubMed ID: 11845984
    [Abstract] [Full Text] [Related]

  • 39. [Polycythemia vera and pregnancy: difficulties for diagnosis and treatment].
    Deruelle P, Bouhassoun J, Trillot N, Jude B, Ducloy AS, Subtil D.
    Gynecol Obstet Fertil; 2005 May 20; 33(5):331-7. PubMed ID: 15878688
    [Abstract] [Full Text] [Related]

  • 40. Hydroxychloroquine, hydroxyurea and didanosine as initial therapy for HIV-infected patients with low viral load: safety, efficacy and resistance profile after 144 weeks.
    Paton NI, Aboulhab J.
    HIV Med; 2005 Jan 20; 6(1):13-20. PubMed ID: 15670247
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.